Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-08-26

Clinical Trial Update: A Phase I/II Trial of Ribavirin (With Escalation) + Isoprinosine in Asymptomatic HIV-Viremic Patients [Phase 1]

View source ↗

Summary

This entry describes a Phase I/II trial evaluating ribavirin (with escalation) plus isoprinosine in asymptomatic HIV-viremic patients. The study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isoprinosine (inosine pranobex)
  • Ribavirin (ribavirin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED